IL-18 production is a hallmark of several monogenic immunodeficiencies that produce IBD symptoms, including macrophage activation syndrome (MAS) secondary to NLRC4 mutation, as well as mutations in X-linked inhibitor of apoptosis (XIAP). Here, NLRC4 is linked to macrophage activation syndrome.